Difficulty: Medium
Average Score: 66%
Practice
During an acute exacerbation, a patient with SLE is treated with corticosteroids. The nurse would expect the corticosteroids to begin to be tapered when which serum laboratory results are evident?
Correct answer
B
Rationale
In the context of Systemic Lupus Erythematosus (SLE) and corticosteroid treatment, an increase in complement levels indicates disease activity is controlled. Therefore, the correct answer is B) Increased complement. Corticosteroids help suppress inflammation and immune response in SLE, leading to a decrease in complement consumption. This reduction in complement levels signifies that the treatment is effective, and tapering can be initiated.
A) Decreased anti-DNA is incorrect because while a decrease may indicate some improvement, it is not as specific as complement levels in assessing disease activity in SLE.
C) Increased red blood cells (RBCs) and D) Decreased erythrocyte sedimentation rate (ESR) are not directly related to the disease activity or response to corticosteroid treatment in SLE.
Educational Context:
Understanding the rationale behind laboratory monitoring in SLE patients receiving corticosteroid therapy is crucial for nurses and healthcare providers. Monitoring complement levels helps in assessing disease activity and treatment effectiveness, guiding clinical decision-making regarding tapering or adjusting medications. This knowledge ensures optimal patient care and management of SLE, emphasizing the importance of evidence-based practice in nursing.
A) Decreased anti-DNA is incorrect because while a decrease may indicate some improvement, it is not as specific as complement levels in assessing disease activity in SLE.
C) Increased red blood cells (RBCs) and D) Decreased erythrocyte sedimentation rate (ESR) are not directly related to the disease activity or response to corticosteroid treatment in SLE.
Educational Context:
Understanding the rationale behind laboratory monitoring in SLE patients receiving corticosteroid therapy is crucial for nurses and healthcare providers. Monitoring complement levels helps in assessing disease activity and treatment effectiveness, guiding clinical decision-making regarding tapering or adjusting medications. This knowledge ensures optimal patient care and management of SLE, emphasizing the importance of evidence-based practice in nursing.